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Correction
After the publication of this work [1], we became aware
of the fact that there was date mistakes in the Abstract,
Patients and method and Results sections. The correct
text is included below.
In the ‘Methods’ section of the Abstract, the first sen-
tence should have read:
“The clinical and follow-up data of 124 patients who
were referred to our department for SIRT between June
2008 and October 2010 were evaluated retrospectively.”
In The ‘Patients’ section of the Patients and Method,
the first sentence should have read:
“The clinical and follow-up data of 124 patients who
were referred to our department for SIRT between June
2008 and October 2010 were evaluated retrospectively.”
In the ‘Patients’ section of the Results, the first sen-
tence should have read:
“78 patients (49 M; 29 F; mean age: 62.4+2.3 years)
received intra-arterial radionuclide treatments with 90 Y
for liver metastasis or primary HCC between June 2008
and October 2010.”
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